Advanced Search


Study ID Status Title Patient Level Data
201393 Completed PGx7572: An Exploratory Investigation of CYP2D6 Activity and Efficacy of tafenoquine and primaquine in TAF112582 Part 1
201398 Completed An Exploratory Meta-Analysis of the Efficacy of Dolutegravir across Subgroups
201402 Completed A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions Study Listed on
201426 Completed PRJ2250: Survey of patient and prescriber understanding of risks associated with TROBALT
201435 Completed A randomised, multi-centre, open label, cross-over non-inferiority study to evaluate efficacy, safety and tolerability of Neumoterol 400 and Symbicort Forte in adults with asthma
201450 Not yet recruiting ENCRUSE ELLIPTA Drug Use Investigation
201463 Completed Measurement of neutrophil retention in the lung in vivo, using autologous labelled neutrophils, in healthy subjects following lipopolysaccharide or saline challenge and patients with chronic obstructive pulmonary disease (COPD)
201465 Completed A Phase I Trial to Evaluate Safety and Efficacy of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test
201474 Completed A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects with Allergic Rhinitis Study Listed on
201477 Completed Duration of Protection Following Five Doses of GlaxoSmithKline’s (GSK’s) DTaP Vaccines in School Age Children
201479 Completed A Phase I Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 in Subjects with Hepatic Impairment and Healthy Matched Control Subjects
201486 Completed PGX6475: PGx evaluation of HLA alleles with rash in lapatinib treated patients from TEACH (EGF105485)
201490 Completed PGx7591: Pharmacogenetic Evaluation of HLA effect on safety events in systemic lupus erythematosus patients treated with GSK2586184 in study JAK115919
201510 Completed An observer-blind study to assess the safety, reactogenicity and immunogenicity of different formulations of GSK Biologicals’ investigational RSV vaccine (GSK3003891A), in healthy women
201512 Active, Not Recruiting Clinical and economic outcomes associated with use of fluticasone propionate 250 mcg and salmeterol 50 mcg combination versus tiotropium as initial maintenance treatment for chronic obstructive pulmonary disease in a managed care setting
201514 Active, Not Recruiting Impact of initiating maintenance treatment (MT) promptly post-chronic obstructive pulmonary disease (COPD) exacerbation in a managed care setting
201527 Completed Comparative Randomized, Single dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole from Idiazole 20mg DR tabs (GSK, Egypt)and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a Single Oral Dose Administration of each to Healthy Adults under Fasting Conditions Study Listed on
201528 Completed Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Rabeprazole from Raperazole 20mg DR tabs (GSK, Egypt) and PARIET 20 mg DR tabs (JANSSEN, EGYPT) after a single oral dose administration of each to healthy adults under fed conditions Study Listed on
201529 Completed Comparative Randomized, Single Dose, Two-way Crossover, Open-label Study to Determine the Bioequivalence of Cefadroxil from Duricef 1 gm Film Coated Tablets (Smithkline Beecham Egypt, LLC Affiliated Co. to GalaxoSmithKline ) and Biodroxil 1 gm Film Coated tablets (Kahira Pharm &Chem .Ind. Co. for Novartis Pharma ) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions Study Listed on
201530 Active, Not Recruiting Qualitative Feasibility of Patient-Centered Mixed-Methods Analysis of SLE Patient Experience Trajectories: The BLISS Trials
201539 Active, Not Recruiting A retrospective data collection of the parameters required as per Belgian reimbursement criteria in SLE patients having received belimumab
201544 Completed A single centre, three part, randomised, study to evaluate the safety, tolerability and pharmacokinetics of GSK2269557 administered via the ELLIPTA™ dry powder inhaler to Healthy Subjects
201546 Completed 201546, A repeat-dose study of batefenterol/FF (GSK961081/GW685698) compared with placebo in the treatment of COPD
201558 Completed A single centre, single blind study to investigate the safety, tolerability and pharmacokinetics of single doses of oxytocin (GR121619) administered via an inhaled route in healthy female volunteers Study Listed on
201568 Completed PGx7589: PGx Investigation of Efficacy by Meta-Analysis of Dabrafenib/Trametinib Melanoma Studies BRF113710, BRF113929, BRF113683, MEK114267 and MEK115306



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.